Skip to main content
. 2023 Feb 24;21:1921–1929. doi: 10.1016/j.csbj.2023.02.045

Fig. 4.

Fig. 4

The ALDH2 proteomic expression profile based on different pathways in LUAD. UALCAN analysis total ALDH2 proteomic expression profile based on HIPPO, mTOR, MYC/MYCN, Chromatin modifier, RTK, SWI-SNF complex, WNT, p53/Rb and NRF2 pathway status. The CPTAC-LUAD including 111 cases was used. Protein expression of ALDH2 were quantified by mass spectrometry method. Z-values represent standard deviations from the median across samples for the given cancer type.